166 related articles for article (PubMed ID: 24068731)
1. STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity.
Betts BC; Veerapathran A; Pidala J; Yu XZ; Anasetti C
J Leukoc Biol; 2014 Feb; 95(2):205-13. PubMed ID: 24068731
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Optimizing iTreg differentiation: STATs in the balance.
Williams CB; Chatila TA
J Leukoc Biol; 2014 Feb; 95(2):197-8. PubMed ID: 24482484
[No Abstract] [Full Text] [Related]
3. CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.
Betts BC; Sagatys EM; Veerapathran A; Lloyd MC; Beato F; Lawrence HR; Yue B; Kim J; Sebti SM; Anasetti C; Pidala J
J Leukoc Biol; 2015 Apr; 97(4):807-19. PubMed ID: 25663681
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
[TBL] [Abstract][Full Text] [Related]
5. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells.
Lee JH; Ulrich B; Cho J; Park J; Kim CH
J Immunol; 2011 Aug; 187(4):1778-87. PubMed ID: 21768398
[TBL] [Abstract][Full Text] [Related]
6. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
7. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
8. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
[TBL] [Abstract][Full Text] [Related]
9. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
10. A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells.
Guo Z; Khattar M; Schroder PM; Miyahara Y; Wang G; He X; Chen W; Stepkowski SM
J Immunol; 2013 Apr; 190(7):3153-62. PubMed ID: 23427250
[TBL] [Abstract][Full Text] [Related]
11. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
[TBL] [Abstract][Full Text] [Related]
12. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome.
Zheng Y; Wang Z; Deng L; Zhang G; Yuan X; Huang L; Xu W; Shen L
Clin Immunol; 2015 Mar; 157(1):65-77. PubMed ID: 25572535
[TBL] [Abstract][Full Text] [Related]
13. Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.
Semple K; Yu Y; Wang D; Anasetti C; Yu XZ
Biol Blood Marrow Transplant; 2011 Mar; 17(3):309-18. PubMed ID: 21224010
[TBL] [Abstract][Full Text] [Related]
14. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
15. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation.
Yuan X; Dou Y; Wu X; Wei Z; Dai Y
J Cell Mol Med; 2017 Sep; 21(9):2172-2183. PubMed ID: 28332288
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells.
Son HJ; Lee SH; Lee SY; Kim EK; Yang EJ; Kim JK; Seo HB; Park SH; Cho ML
J Immunol; 2017 Feb; 198(4):1484-1491. PubMed ID: 28093521
[TBL] [Abstract][Full Text] [Related]
18. Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance.
Tibbitt C; Falconer J; Stoop J; van Eden W; Robinson JH; Hilkens CM
Eur J Immunol; 2016 Jul; 46(7):1633-43. PubMed ID: 27173727
[TBL] [Abstract][Full Text] [Related]
19. Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells.
Ma J; Liu Y; Li Y; Gu J; Liu J; Tang J; Wang J; Ryffel B; Shen Y; Brand D; Liu Z; Zheng SG
J Leukoc Biol; 2014 Feb; 95(2):275-83. PubMed ID: 24082012
[TBL] [Abstract][Full Text] [Related]
20. IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.
Basu R; Whitley SK; Bhaumik S; Zindl CL; Schoeb TR; Benveniste EN; Pear WS; Hatton RD; Weaver CT
Nat Immunol; 2015 Mar; 16(3):286-95. PubMed ID: 25642823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
